Exclusive | Zoho CEO Mani Vembu on Arattai’s 100X surge: In this candid conversation with Zoho CEO Mani Vembu, dive into how Zoho’s 20-year-old tech backbone powers Arattai - the homegrown messaging app that saw a “100X surge” amid an explosive user growth. Mani Vembu shares insights on: Why India needs this tech: “Need this tech within India for data sovereignty” The massive rollout plans: “We were planning for wider rollout in November, but the scale became unimaginable.” Arattai’s growth milestones: “Meetings crossing 100,000 every day” and “More than half a million calls every day.” Competing with WhatsApp, Signal & Telegram: “Every app stands on its own merit… We will have our own space.” Building a super app: “Looking at adding more services. Payment is one of the areas we are looking to integrate.” Commitment to product & privacy: “We keep focus on improving the product… Users should find the app valuable.” Future features: “Have an option called Secret Chat, will enable end-to-end encryption soon.” This interview reveals the vision behind Arattai, Zoho’s long-term investment philosophy -“Learning by doing” - and how they are powering India’s digital independence. Mani Vembu spoke to Monecontrol's Chandra R Srikanth and Bhavya Dilipkumar
Harsh Gahlaut of FinEdge believess from the next quarter onwards, the trend is likely to shift towards earnings upgrades rather than downgrades.
NPS to offer same tax benefits to new inflation-protected payouts; 100% equity option already available
Abhishek Banerjee of Lotusdew Wealth is quite bullish on formalization of economy which can be seen as increased GST collection even after GST tax cuts as well as increasing EPFO contributions.
The delay in the India-US trade deal presents significant threats to Indian equity markets that could potentially undermine the anticipated earnings recovery, Robin Arya of GoalFi said.
The zone of 25,050–25,100 will act as a crucial resistance area for the Nifty 50, as it coincides with the 61.8 percent Fibonacci retracement of the recent decline, said Sudeep Shah of SBI Securities.
The support for the Bank Nifty is around 54,800 while next resistance is around 55,800 and 56,500 for the next few sessions, Arun Kumar Mantri said.
Ashish Chaturmohta of JM Financial is particularly positive on companies poised to benefit from a rural consumption recovery, which forms a significant part of overall demand.
Overall, the daily and weekly timeframe trend continue to be in a sideways band Nifty 50. There is no clear direction as far as Nifty is concerned, said Rahul Ghose of Hedged.
During the recent market correction, we have observed compelling investment opportunities emerging across both consumption-driven and investment-led themes, said Hemant Kanawala of Kotak Mahindra Life Insurance.
Markets are now looking for something more concrete, be it a strong earnings surprise, significant trade measures with major partners, or a major geopolitical breakthrough to justify a move to new highs, said Raghvendra Nath of Ladderup Asset Managers.
Divam Sharma of Green Portfolio remainss cautiously optimistic on food delivery sector as the sector still faces competitive intensity and changing consumer preferences.
India–US trade deal offers sector-specific benefits in electronics, agri-tech, and industrial goods, but not as a market-defining catalyst, said Shriram Wealth's Vikas Satija.
Bharti Airtel and Larsen & Toubro would be my picks for next week, said Milan Vaishnav.
Varun Lohchab does not anticipate a significant slowdown in aggregate earnings for Q2FY26, although some sectors may experience mild softness.
Current corporate earnings growth expectations are conservative, suggesting that further estimate cuts are unlikely, said Shailendra Kumar of Narnolia Financial Services.
On the technical front, Nifty has broken below key short-term moving averages — the 20-day, 50-day, and 100-day EMAs — all of which have now turned downward, signalling weakness in trend structure, said Sudeep Shah of SBI Securities.
With India supplying 45% of US generic drugs and the US being the largest pharma export market worth $8.7 billion in FY24, any escalation beyond current measures could fundamentally alter sector dynamics, said Anil Rego of Right Horizons.
The domestic story remains supportive, but a robust rebound toward record highs will likely require a strong trade agreement to ease market concerns, Anirudh Garg of INVasset PMS said.
Dikshit Mittal of LIC MF anticipates a meaningful pickup in earnings momentum starting from Q3FY26, driven by themes such as consumption, BFSI, manufacturing, and capex.
Anuj Jain of Green Portfolio believes Donald Trump is using the H-1B visa issue as a tactical measure in trade negotiations with India.
Besides many other factors, the gold prices are probably rallying since several central banks across the world are reducing exposure to the USD and increasing to alternatives including gold, Vikas Gupta of Omniscience Capital said.
The recent improvement in US–India relations raises the possibility of the 25% additional tariff on Indian goods being rolled back, which could trigger a relief rally toward the end of CY25, Rakesh Vyas of Quest Investment Advisors said.
The supportive policy backdrop and global liquidity easing set the stage for earnings upgrades rather than downgrades over the coming 2–3 quarters, said Sonam Srivastava.
A durable move to new markets highs would still need support from earnings revisions and global rates rather than tariffs alone, says Arindam Mandal of Marcellus.